WHO ICTRP trial
India Glaucoma Outcomes and Treatment Trial
ISRCTN52778666 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN52778666 |
|---|---|
| Public title | India Glaucoma Outcomes and Treatment Trial |
| Scientific title | India Glaucoma Outcomes and Treatment Trial |
| Primary sponsor | Pfizer Inc. (USA) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | India |
| Conditions | Glaucoma Eye Diseases Glaucoma |
| Interventions | Medicine (timolol, latanaprost and brimonidine) versus surgery |
| Registration date | Mar 30, 2006 |
| Target size | 700 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: